WallStreetZenWallStreetZen

NYSEMKT: SER
Serina Therapeutics Inc Stock Ownership - Who owns Serina Therapeutics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Serina Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Randall MoreadithChief Scientific Officer2026-03-1939,000$2.50
$97.50kSell
Randall MoreadithChief Scientific Officer2026-03-1939,000$0.06
$2.34kBuy
Randall MoreadithChief Scientific Officer2026-02-026,500$3.03
$19.68kSell
Randall MoreadithChief Scientific Officer2026-02-026,500$0.06
$390.00Buy
Randall MoreadithChief Scientific Officer2026-01-286,500$0.06
$390.00Buy
Randall MoreadithChief Scientific Officer2026-01-286,500$3.57
$23.19kSell
Randall MoreadithChief Scientific Officer2026-01-222,500$2.95
$7.38kSell
Randall MoreadithChief Scientific Officer2026-01-222,500$0.06
$150.00Buy
Randall MoreadithChief Scientific Officer2026-01-212,000$3.00
$6.00kSell
Randall MoreadithChief Scientific Officer2026-01-212,000$0.06
$120.00Buy

1 of 8

SER insiders have bought as... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when SER insiders and whales buy or sell their stock.

SER Shareholders

What type of owners hold Serina Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Juvenescence Ltd210.82%22,481,876$57.10MInsider
Juvenescence Us Corp154.23%16,447,500$41.78MInsider
Steven A. Ledger3.04%323,657$822.09kInsider
Vanguard Group Inc1.69%180,013$457.23kInstitution
John F. Mauldin1.17%125,000$317.50kInsider
Waverly Advisors LLC0.63%67,492$171.43kInstitution
Gregory Bailey0.63%67,243$170.80kInsider
Tacey Viegas0.55%58,610$148.87kInsider
Broadwood Capital Inc0.51%54,484$138.39kInstitution
Judith Segall0.49%52,624$133.66kInsider

1 of 3

SER vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
SER1.07%98.93%Net BuyingNet Buying
TVRD8.39%91.61%
JSPR28.27%71.73%Net Buying
INMB19.12%27.83%
RADX2.18%0.00%
View Top Biotech Stocks

Serina Therapeutics Stock Ownership FAQ

Who owns Serina Therapeutics?

Serina Therapeutics (NYSEMKT: SER) is owned by 4.03% institutional shareholders, 372.02% Serina Therapeutics insiders, and 0.00% retail investors. Juvenescence Ltd is the largest individual Serina Therapeutics shareholder, owning 22.48M shares representing 210.82% of the company. Juvenescence Ltd's Serina Therapeutics shares are currently valued at $70.82M.

If you're new to stock investing, here's how to buy Serina Therapeutics stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.